Statement of Ownership (sc 13g)
2021年2月13日 - 6:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
PMV
PHARMACEUTICALS, INC.
(Name of Issuer)
Common Stock, par value $0.00001
(Title of Class of Securities)
69353Y 103
(CUSIP
Number)
December 31, 2020
(Date of Event Which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule
13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
*
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
|
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of
the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
Euclidean Capital LLC
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
5
|
|
SOLE VOTING POWER
0
|
|
6
|
|
SHARED VOTING POWER
4,179,416
|
|
7
|
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
|
SHARED DISPOSITIVE POWER
4,179,416
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,179,416
|
10
|
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW 9
9.3%
|
12
|
|
TYPE OF REPORTING PERSON
(SEE INSTRUCTIONS)
OO
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
James H. Simons
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United States of
America
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
5
|
|
SOLE VOTING POWER
0
|
|
6
|
|
SHARED VOTING POWER
4,179,416
|
|
7
|
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
|
SHARED DISPOSITIVE POWER
4,179,416
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,179,416
|
10
|
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW 9
9.3%
|
12
|
|
TYPE OF REPORTING PERSON
(SEE INSTRUCTIONS)
IN
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
Marilyn H. Simons
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United States of
America
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
5
|
|
SOLE VOTING POWER
0
|
|
6
|
|
SHARED VOTING POWER
4,179,416
|
|
7
|
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
|
SHARED DISPOSITIVE POWER
4,179,416
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,179,416
|
10
|
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW 9
9.3%
|
12
|
|
TYPE OF REPORTING PERSON
(SEE INSTRUCTIONS)
IN
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
Ashvin B. Chhabra
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United States of
America
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
5
|
|
SOLE VOTING POWER
0
|
|
6
|
|
SHARED VOTING POWER
4,179,416
|
|
7
|
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
|
SHARED DISPOSITIVE POWER
4,179,416
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,179,416
|
10
|
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW 9
9.3%
|
12
|
|
TYPE OF REPORTING PERSON
(SEE INSTRUCTIONS)
IN
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
Greenland NFP B Ltd.
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
British Virgin
Islands
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
5
|
|
SOLE VOTING POWER
0
|
|
6
|
|
SHARED VOTING POWER
2,601,637
|
|
7
|
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
|
SHARED DISPOSITIVE POWER
2,601,637
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,601,637
|
10
|
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW 9
5.8%
|
12
|
|
TYPE OF REPORTING PERSON
(SEE INSTRUCTIONS)
OO
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
Greenland NFP LLC
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
5
|
|
SOLE VOTING POWER
0
|
|
6
|
|
SHARED VOTING POWER
132,601
|
|
7
|
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
|
SHARED DISPOSITIVE POWER
132,601
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
132,601
|
10
|
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW 9
0.3%
|
12
|
|
TYPE OF REPORTING PERSON
(SEE INSTRUCTIONS)
OO
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
Greenland FP LLC
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
5
|
|
SOLE VOTING POWER
0
|
|
6
|
|
SHARED VOTING POWER
751,409
|
|
7
|
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
|
SHARED DISPOSITIVE POWER
751,409
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
751,409
|
10
|
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW 9
1.7%
|
12
|
|
TYPE OF REPORTING PERSON
(SEE INSTRUCTIONS)
OO
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
Greenland A LLC
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
5
|
|
SOLE VOTING POWER
0
|
|
6
|
|
SHARED VOTING POWER
693,769
|
|
7
|
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
|
SHARED DISPOSITIVE POWER
693,769
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
693,769
|
10
|
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW 9
1.5%
|
12
|
|
TYPE OF REPORTING PERSON
(SEE INSTRUCTIONS)
OO
|
Item 1(a).
|
Name of Issuer:
|
PMV Pharmaceuticals, Inc. (the Issuer)
Item 1(b).
|
Address of Issuers Principal Executive Offices:
|
8 Clarke Drive, Suite 3
Cranbury, NJ 08512
Item 2(a).
|
Names of Persons Filing:
|
The names of the persons filing this report (collectively, the Reporting Persons) are:
Euclidean Capital LLC (Euclidean Capital)
James H. Simons (Mr. Simons)
Marilyn H. Simons (Mrs. Simons)
Ashvin B. Chhabra (Mr. Chhabra)
Greenland A LLC
Greenland FP LLC
Greenland NFP B Ltd.
Greenland NFP LLC
Item 2(b).
|
Address of Principal Business Office or, if None, Residence:
|
The address of the principal business office of each of the Reporting Persons is:
160 Fifth Avenue, 9th Floor
New York, NY 10010
Euclidean Capital is a Delaware limited liability company
Mr. Simons is a United States citizen
Mrs. Simons is a United States citizen
Mr. Chhabra is a United States citizen
Greenland A LLC is a Delaware limited liability company
Greenland FP LLC is a Delaware limited liability company
Greenland NFP B Ltd. is a share company incorporated in the British Virgin Islands
Greenland NFP LLC is a Delaware limited liability company
Item 2(d).
|
Title of Class of Securities:
|
Common Stock, par value $0.00001 (Common Stock)
69353Y 103
Item 3.
|
If this statement is filed pursuant to §§ 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
|
Not
applicable.
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this
Schedule 13G. The ownership percentages are based on 44,773,748 outstanding shares of Common Stock as reported in the Issuers Form 10-Q filed on November 13, 2020.
Euclidean is the manager of each of Greenland A LLC, Greenland FP LLC, Greenland NFP B Ltd., and Greenland NFP LLC. Mrs. Simons and
Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean.
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of
more than five percent of the class of securities, check the following ☐.
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not applicable.
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company or Control Person.
|
Not applicable.
Item 8.
|
Identification and Classification of Members of the Group.
|
Not applicable.
Item 9.
|
Notice of Dissolution of Group.
|
Not applicable.
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Date: February 12, 2021
|
|
|
EUCLIDEAN CAPITAL LLC
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager
|
|
|
/s/ James H. Simons
|
JAMES H. SIMONS
|
|
|
/s/ Marilyn H. Simons
|
MARILYN H. SIMONS
|
|
|
/s/ Ashvin B. Chhabra
|
ASHVIN B. CHHABRA
|
|
|
|
GREENLAND A LLC
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager of Euclidean Capital LLC, its Manager
|
|
|
|
GREENLAND FP LLC
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager of Euclidean Capital LLC, its Manager
|
|
|
|
GREENLAND NFP B LTD.
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager of Euclidean Capital LLC, its Vice President
|
|
|
|
GREENLAND NFP LLC
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager of Euclidean Capital LLC, its Manager
|
EXHIBIT 1
AGREEMENT
The persons below hereby agree that
the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
Date: February 12, 2021
|
|
|
EUCLIDEAN CAPITAL LLC
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager
|
|
|
/s/ James H. Simons
|
JAMES H. SIMONS
|
|
|
/s/ Marilyn H. Simons
|
MARILYN H. SIMONS
|
|
|
/s/ Ashvin B. Chhabra
|
ASHVIN B. CHHABRA
|
|
|
|
GREENLAND A LLC
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager of Euclidean Capital LLC, its Manager
|
|
|
|
GREENLAND FP LLC
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager of Euclidean Capital LLC, its Manager
|
|
|
|
GREENLAND NFP B LTD.
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager of Euclidean Capital LLC, its Vice President
|
|
|
|
GREENLAND NFP LLC
|
|
|
By:
|
|
/s/ Joseph Cosmai
|
|
|
Name: Joseph Cosmai
|
|
|
Title: Manager of Euclidean Capital LLC, its Manager
|
PMV Pharmaceuticals (NASDAQ:PMVP)
過去 株価チャート
から 6 2024 まで 7 2024
PMV Pharmaceuticals (NASDAQ:PMVP)
過去 株価チャート
から 7 2023 まで 7 2024